Jin Soo - AptaBio Therapeutics Chief Officer
| 293780 Stock | 6,590 310.00 4.94% |
Insider
Jin Soo is Chief Officer of AptaBio Therapeutics
| Phone | 82 70 7152 0097 |
| Web | http://www.aptabio.com |
AptaBio Therapeutics Management Efficiency
The company has return on total asset (ROA) of (0.0568) % which means that it has lost $0.0568 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (17.4655) %, meaning that it generated substantial loss on money invested by shareholders. AptaBio Therapeutics' management efficiency ratios could be used to measure how well AptaBio Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities.Management Performance
| Return On Equity | -17.47 | |||
| Return On Asset | -0.0568 |
AptaBio Therapeutics Leadership Team
Elected by the shareholders, the AptaBio Therapeutics' board of directors comprises two types of representatives: AptaBio Therapeutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of AptaBio. The board's role is to monitor AptaBio Therapeutics' management team and ensure that shareholders' interests are well served. AptaBio Therapeutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, AptaBio Therapeutics' outside directors are responsible for providing unbiased perspectives on the board's policies.
AptaBio Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is AptaBio Therapeutics a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -17.47 | |||
| Return On Asset | -0.0568 | |||
| Operating Margin | (17.13) % | |||
| Current Valuation | 794.49 B | |||
| Shares Outstanding | 10.88 M | |||
| Shares Owned By Insiders | 34.04 % | |||
| Shares Owned By Institutions | 3.46 % | |||
| Price To Sales | 926.14 X | |||
| Revenue | 223.68 M | |||
| Gross Profit | 336.97 M |
Pair Trading with AptaBio Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if AptaBio Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AptaBio Therapeutics will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to AptaBio Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace AptaBio Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back AptaBio Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling AptaBio Therapeutics to buy it.
The correlation of AptaBio Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as AptaBio Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if AptaBio Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for AptaBio Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in AptaBio Stock
AptaBio Therapeutics financial ratios help investors to determine whether AptaBio Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in AptaBio with respect to the benefits of owning AptaBio Therapeutics security.